Trial Profile
A randomized, two-way crossover study to investigate the bioavailability of a single oral dose of 37.5 mg carbidopa, 150 mg levodopa and 200 mg entacapone compared to a single oral combined dose of both 37.5 mg carbidopa and 150 mg levodopa and 200 mg entacapone in healthy volunteers under fasting conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Mar 2007
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa/entacapone (Primary) ; Carbidopa; Entacapone; Levodopa
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Novartis
- 29 Mar 2007 New trial record.